[1] van Westreenen HL, Westerterp M, Jager PL, et al. Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer. J Nucl Med, 2005, 46(8):1321-1325.
[2] Kato H, Kuwano H, Nakajima M, et al. Comparison between positron assessment of esophageal carcinoma. Cancer, 2002, 94(4):921-928.
[3] Cham D, Henderson R, Conti PS. Virchow's node on 18F-FDG PET/CT. Clin Nucl Med, 2004, 29(11):770-772.
[4] Skehan SJ, Brown AL, Thompson M, et al. Imaging features of primary and recurrent esophageal cancer at FDG PET. Radiographics, 2000, 20(3):713-723.
[5] Swisher SG, Maish M, Erasmus JJ, et al. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg, 2004, 78(4):1152-1160.
[6] Sihvo EI, Rasanen JV, Knuuti MJ, et al. Adenocarcinoma of the esophagus and the esophagogastric junction:positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease. J Gastrointest Surg, 2004, 8(8):988-996.
[7] Kostakoglu L, Goldsmith SJ. PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus. J Nucl Med, 2004, 45(1):56-68.
[8] Touboul E, Deniaud-Alexandre E, Moureau-Zabotto L, et al. The impact of integrating images of positron emission tomography with computed tomography simulation on radiation therapy planning.Cancer Radiother. 2004, 8(Suppl 1):S29-S35.
[9] Nakamoto Y, Osman M, Cohade C, et al. PET/CT:comparison of quatltative tracer uptake between germanium and CT transmission attenuation-corrected images. J Nucl Med, 2002, 43(9):1137-1143.
[10] Bar-Shalom R, Guralnik L, Tsalic M, et al. The additional value of PET/CT over PET in FDG imaging of oesophageal cancer. Eur J Nucl Med Mol Imaging, 2005, 32(8):918-924.
[11] Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med, 2000, 41(8):1369-1379.
[12] Leong T, Everitt C, Yuen K, et al. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother Oncol, 2006, 78(3):254-261.